Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial

被引:9
作者
Xie, Jinrong [1 ]
Xu, Feifei [1 ]
Zhao, Yutian [2 ]
Cai, Gang [1 ]
Lin, Xiao [3 ,4 ]
Zhu, Qiwei [5 ]
Lin, Qing [6 ]
Yao, Yuan [7 ]
Xu, Cheng [1 ]
Cai, Rong [1 ]
Wang, Shubei [1 ]
Tang, Xiaolu [1 ]
Chen, Chuying [1 ]
Zheng, Siyue [1 ]
Chen, Mei [1 ]
Chen, Min [1 ]
Qian, Xiaofang [1 ]
Shen, Chunhong [1 ]
Li, Jian [8 ]
Xu, Haoping [1 ]
Xu, Fei [1 ]
Han, Yimin [1 ]
Li, Min [1 ]
Ou, Dan [1 ]
Shen, Kun Wei [9 ]
Qi, Wei-Xiang [1 ]
Cao, Lu [1 ]
Huang, Xiaobo [3 ,4 ,10 ]
Chen, Jiayi [1 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Ruijin Hosp, Med Sch, Dept Radiat Oncol, Shanghai, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Radiat Oncol, Wuxi, Jiangsu, Peoples R China
[3] Sun Yat Sen Univ, Yat Sen Breast Tumor Hosp, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China
[5] Nantong Univ, Affiliated Tumor Hosp, Dept Radiat Oncol, Nantong, Jiangsu, Peoples R China
[6] Shanghai Tenth Peoples Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
[7] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 9, Sch Med, Dept Radiat Oncol, Shanghai, Peoples R China
[8] Shanghai Jiao Tong Univ, Ruijin Hosp, Clin Res Ctr, Sch Med, Shanghai, Peoples R China
[9] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gen Surg,Comprehens Breast Hlth Ctr, Shanghai, Peoples R China
[10] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China
关键词
EARLY BREAST-CANCER; TARGET VOLUME DELINEATION; RADIOTHERAPY HYPOFRACTIONATION; UK STANDARDIZATION; INTERNAL MAMMARY; CAPSULAR CONTRACTURE; SENTINEL NODE; THERAPY; RECONSTRUCTION; IMPLANT;
D O I
10.1136/bmjopen-2022-062034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Short course regimen has become the major trend in the field of adjuvant radiotherapy for patients with breast cancer. Hypofractionated radiotherapy (HF-RT) regimen of 40-42.5 Gy in 15-16 fractions has been established as a preferred option for whole breast irradiation. However, few evidences of hypofractionated regional nodal irradiation (RNI), especially involving internal mammary nodes (IMNs), could be available during the era of intensity-modulated radiation therapy (IMRT). Against this background, we design this trial to explore the hypothesis that HF-RT regimen involving RNI (including infraclavicular, supraclavicular nodes and IMNs) will be non-inferior to a standard schedule by using IMRT technique. Methods and analysis This is an open-label randomised, non-inferior, multicentre phase III trial. Patients with breast cancer with an indication for RNI after breast conserving surgery or mastectomy are randomised at a ratio of 1:1 into the following two groups: hypofractionated regimen of 2.67 Gy for 16 fractions or conventional regimen of 2 Gy for 25 fractions. The dose was prescribed to ipsilateral chest wall or whole breast and RNI (including infraclavicular, supraclavicular nodes and IMNs, lower axilla if indicated). The trial plans to enrol a total of 801 patients and all patients will be treated using IMRT technique. The primary endpoint is 5-year locoregional recurrence. The secondary endpoints include 5-year distant metastasis free survival, invasive recurrence-free survival, overall survival, accumulative acute radiation-induced toxicity and accumulative late radiation-induced toxicity, cosmetic outcomes and quality of life. Ethics and dissemination The study has been approved by the Ethical Committee of Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine (version 2018-95-3) and approvals from ethical committee of each participating centre have also been obtained. Research findings will be submitted for publication in peer-reviewed journals.
引用
收藏
页数:11
相关论文
共 48 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]   Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications [J].
Batumalai, Vikneswary ;
Delaney, Geoff P. ;
Descallar, Joseph ;
Gabriel, Gabriel ;
Wong, Karen ;
Shafiq, Jesmin ;
Barton, Michael .
RADIOTHERAPY AND ONCOLOGY, 2020, 152 :70-77
[3]   Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008-2013 [J].
Bekelman, Justin E. ;
Sylwestrzak, Gosia ;
Barron, John ;
Liu, Jinan ;
Epstein, Andrew J. ;
Freedman, Gary ;
Malin, Jennifer ;
Emanuel, Ezekiel J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (23) :2542-2550
[4]  
Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7
[5]  
Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)60348-7, 10.1016/S1470-2045(08)70077-9]
[6]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[7]   Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial [J].
Brunt, Adrian Murray ;
Haviland, Joanne S. ;
Wheatley, Duncan A. ;
Sydenham, Mark A. ;
Alhasso, Abdulla ;
Bloomfield, David J. ;
Chan, Charlie ;
Churn, Mark ;
Cleator, Susan ;
Coles, Charlotte E. ;
Goodman, Andrew ;
Harnett, Adrian ;
Hopwood, Penelope ;
Kirby, Anna M. ;
Kirwan, Cliona C. ;
Morris, Carolyn ;
Nabi, Zohal ;
Sawyer, Elinor ;
Somaiah, Navita ;
Stones, Liba ;
Syndikus, Isabel ;
Bliss, Judith M. ;
Yarnold, John R. .
LANCET, 2020, 395 (10237) :1613-1626
[8]   Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab [J].
Cao, Lu ;
Cai, Gang ;
Chang, Cai ;
Miao, Ai-Yu ;
Yu, Xiao-Li ;
Yang, Zhao-Zhi ;
Ma, Jin-Li ;
Zhang, Qian ;
Wu, Jiong ;
Guo, Xiao-Mao ;
Chen, Jia-Yi .
ONCOLOGIST, 2015, 20 (06) :605-614
[9]   Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Cardoso, F. ;
Kyriakides, S. ;
Ohno, S. ;
Penault-Llorca, F. ;
Poortmans, P. ;
Rubio, I. T. ;
Zackrisson, S. ;
Senkus, E. .
ANNALS OF ONCOLOGY, 2019, 30 (08) :1194-1220
[10]   Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer [J].
Deshmukh, Ashish A. ;
Shirvani, Shervin M. ;
Lal, Lincy ;
Swint, J. Michael ;
Cantor, Scott B. ;
Smith, Benjamin D. ;
Likhacheva, Anna .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (11)